Radiation Risks of Medical Imaging: Separating Fact from Fantasy | Radiology
PDF) Clinical utility of gallium-68 PSMA PET/CT scan for prostate cancer
Applied Sciences | Free Full-Text | A Combined Protective Dose of Angelica archangelica and Ginkgo biloba Restores Normal Functional Hemoglobin Derivative Levels in Rabbits after Oxidative Stress Induced by Gallium-68 | HTML
![Pharmaceuticals | Free Full-Text | [68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-13-00038/article_deploy/html/images/pharmaceuticals-13-00038-g001.png "Pharmaceuticals | Free Full-Text | [68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging | HTML")
Pharmaceuticals | Free Full-Text | [68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging | HTML
PDF) The “ProPSMA Study” clinical trial protocol: A prospective randomized multi-center study of the impact of Ga-68 PSMA PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study - The Lancet
Radiobiology and Radiation Dosimetry in Nuclear Medicine | SpringerLink
PDF) Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
Theranostics and radiopharmaceuticals in cancer treatment - ScienceDirect
Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors | Journal of Nuclear Medicine
DIAGNOSTIC RADIOISOTOPES S 67 Znp n67 Ga 68
All you need to know about Gallium 68 PET Scans – Ronny Allan – Living with Neuroendocrine Cancer
Diagnostics | Free Full-Text | The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future | HTML
PDF) Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
ICH GCP - FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer - ICH GCP
Gallium-68: Radiolabeling of Radiopharmaceuticals for PET Imaging - A Lot to Consider | IntechOpen
PSMA PET/CT imaging and therapy
Diagnostics | Free Full-Text | Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer | HTML
Third Theranostics World Congress on Gallium-68 and PRRT: Abstracts | Journal of Nuclear Medicine
Radiation Risks of Medical Imaging: Separating Fact from Fantasy | Radiology
Radiobiology and Radiation Dosimetry in Nuclear Medicine | SpringerLink
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and ...
Radiation exposure to nuclear medicine personnel handling positron emitters from Ge-68/Ga-68 generator | Request PDF
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent - European Urology
